These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29980977)

  • 1. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
    Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
    J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
    Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
    Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
    J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; Bell R; White A; Pathak S; Hidalgo E; Lodge P; Prasad R; Toogood G
    ANZ J Surg; 2018 Jan; 88(1-2):66-70. PubMed ID: 27111217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.
    Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss M; Marques HP; Aldrighetti L; Pawlik TM
    J Surg Oncol; 2017 Dec; 116(7):841-847. PubMed ID: 28650564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
    Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
    Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of anatomic and non-anatomic resections for very early-stage hepatocellular carcinoma: The importance of surgical resection margin width in non-anatomic resection.
    Su CM; Chou CC; Yang TH; Lin YJ
    Surg Oncol; 2021 Mar; 36():15-22. PubMed ID: 33276259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blinded prospective randomized trial comparing the effect of anatomic versus non-anatomic resection on hepatocellular carcinoma recurrence.
    Feng X; Su Y; Zheng S; Xia F; Ma K; Yan J; Li X; Tang W; Wang S; Bie P; Dong J
    HPB (Oxford); 2017 Aug; 19(8):667-674. PubMed ID: 28499749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis.
    Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    J Surg Oncol; 2018 Feb; 117(2):171-181. PubMed ID: 28940257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?
    Lalmahomed ZS; Ayez N; van der Pool AE; Verheij J; IJzermans JN; Verhoef C
    World J Surg; 2011 Mar; 35(3):656-61. PubMed ID: 21161655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis.
    Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    Ann Surg Oncol; 2020 Oct; 27(10):3717-3726. PubMed ID: 32436187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Nonanatomical Liver Resection in Diligently Selected Patients with Hepatoblastoma and Comparison of Outcomes with Anatomic Resection.
    Qureshi SS; Kembhavi SA; Kazi M; Smriti V; Baheti A; Vora T; Chinnaswamy G; Prasad M; Amin N; Ramadwar M; Khanna N; Laskar S
    Eur J Pediatr Surg; 2021 Jun; 31(3):236-244. PubMed ID: 32422675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation.
    Joechle K; Vreeland TJ; Vega EA; Okuno M; Newhook TE; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Lee JE; Vauthey JN
    J Gastrointest Surg; 2020 May; 24(5):1033-1039. PubMed ID: 32162236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
    Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
    World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
    Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
    J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation.
    Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Campagnaro T; Ercolani G; Conci S; Giuliante F; Dore A; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Guglielmi A; Iacono C
    J Gastrointest Surg; 2019 Jan; 23(1):93-100. PubMed ID: 30242647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
    Masui T; Nagai K; Anazawa T; Kasai Y; Sato A; Nakano K; Uchida Y; Yogo A; Kawaguchi Y; Takaori K; Uemoto S
    Scand J Gastroenterol; 2020 Apr; 55(4):479-484. PubMed ID: 32223573
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.